FMR LLC - CYTEIR THERAPEUTICS INC ownership

CYTEIR THERAPEUTICS INC's ticker is CYT and the CUSIP is 23284P103. A total of 40 filers reported holding CYTEIR THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.6%.

Quarter-by-quarter ownership
FMR LLC ownership history of CYTEIR THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$2,347,993
+9.1%
826,758
-0.1%
0.00%
Q2 2023$2,152,454
-73.7%
827,867
-81.6%
0.00%
Q1 2023$8,198,484
+70.8%
4,504,662
+54.9%
0.00%
Q4 2022$4,798,820
-28.3%
2,908,376
-16.6%
0.00%
-100.0%
Q3 2022$6,693,000
-42.2%
3,486,058
-10.0%
0.00%0.0%
Q2 2022$11,578,000
-31.8%
3,872,289
-14.0%
0.00%0.0%
Q1 2022$16,969,000
-63.1%
4,501,233
+11.2%
0.00%
-66.7%
Q4 2021$46,036,000
-38.8%
4,048,993
-5.5%
0.00%
-50.0%
Q3 2021$75,213,000
+231.5%
4,285,659
+304.2%
0.01%
+200.0%
Q2 2021$22,688,0001,060,2060.00%
Other shareholders
CYTEIR THERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
OUP Management Co., LLC 2,459,572$4,476,4218.93%
Novo Holdings A/S 3,940,413$112,892,8327.45%
BML Capital Management, LLC 3,146,296$5,726,2594.95%
Newtyn Management, LLC 952,947$1,734,3640.34%
Aldebaran Capital, LLC 151,239$275,2550.28%
Avidity Partners Management LP 1,764,100$3,210,6620.11%
Marquette Asset Management, LLC 67,990$123,7420.03%
TANG CAPITAL MANAGEMENT LLC 100,000$182,0000.03%
RBF Capital, LLC 117,295$213,4770.02%
CAAS CAPITAL MANAGEMENT LP 150,406$273,7390.02%
View complete list of CYTEIR THERAPEUTICS INC shareholders